Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Anorexia 4Weight Loss 2Neoplasms 2Cachexia 2Sleep Initiation and Maintenance Disorders 1Depression 1Carcinoma, Non-Small-Cell Lung 1Body Weight 1Anorexia Nervosa with Significantly Low Body Weight 1

Interventions

Megestrol Acetate 4Mirtazapine 2ostarine 1nabiximols 1clazakizumab 1anamorelin 1Sodium Chloride 1Physical Therapy Modalities 1Omacor 1Olanzapine 1Nutrition Assessment 1Megestrol 1Infliximab 1Ibuprofen 1Gemcitabine 1Flurandrenolone 1Fecal Microbiota Transplantation 1Cyproheptadine 1Clarithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Cachexia × Mirtazapine × Clear all
NCT03283488 2023-07-07

Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.

University of Sao Paulo

Phase 2 Completed
52 enrolled

Anorexia, Cachexia, Neoplasms

NCT05380479 2022-05-18

Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 2 Unknown
80 enrolled

Anorexia, Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡